Rapid culture-based LNZ test for detection of linezolid susceptibility/resistance in staphylococci and enterococci

Diagn Microbiol Infect Dis. 2023 Nov;107(3):116058. doi: 10.1016/j.diagmicrobio.2023.116058. Epub 2023 Aug 11.

Abstract

A rapid, easy-to-handle, cost-effective and universal culture-based test was developed for the identification of linezolid resistance among the most clinically relevant enterococcal and staphylococcal species. Our technique was tested using linezolid-resistant (n = 50) and linezolid-susceptible (n = 67) Gram-positive isolates: 34 Enterococcus faecium, 20 Enterococcus faecalis, 20 Staphylococcus aureus, 38 Staphylococcus epidermidis, and 5 Staphylococcus capitis. The susceptibility/resistance phenotype of E. faecium, E. faecalis, S. aureus, and S. epidermidis to linezolid was detected within 4.5 hours, while an extended timeframe was actually required for S. capitis (6.5 hours). The Rapid LNZ test showed a full agreement with the standard broth microdilution method, independently of the molecular resistance mechanism and MIC values, with sensitivities and specificities of 100% for all species.

Keywords: Enterococci; Staphylococci; linezolid resistance.

MeSH terms

  • Acetamides
  • Anti-Bacterial Agents / pharmacology
  • Drug Resistance, Bacterial
  • Enterococcus
  • Gram-Positive Bacterial Infections*
  • Humans
  • Linezolid / pharmacology
  • Microbial Sensitivity Tests
  • Oxazolidinones*
  • Staphylococcus
  • Staphylococcus aureus

Substances

  • Linezolid
  • Anti-Bacterial Agents
  • Oxazolidinones
  • Acetamides